Late Breaking Abstracts

#168 UPLIFT (ENGOT-Ov67/GOG-3048): results from the phase 2 trial of upifitamab rilsodotin (UpRi; XMT-1536), a NaPi2b-directed dolaflexin antibody-drug conjugate (ADC) in platinum-resistant ovarian cancer (PROC)

Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.1118 Nicole Concin, John L Hays, Alejandro Pérez Fidalgo, B. Pothuri, Susana Banerjee, S. Ghamande, I. Ray-Coquard, Anna Germanova, B. Rimel, Domenica Lorusso, N. Cloven, J. Baurain, Leslie M Randall, Birute Brasiuniene, Jill H Tseng, D. Klasa-Mazurkiewicz, Theresa L Werner, A. Oaknin, Joo Ern Ang, Alexandra Leary, Erin Bishop, Christian Marth, Chelsea Bradshaw, Robert A Burger, Antonio González-Martín, Debra L Richardson

#1074 ESGO endometrial cancer quality indicators between ESGO accredited centre in training and comparable centre pursuing for accreditation

Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.1136 Maja Pakiž, Marko Klaric, Andrej Cokan, G. Primorac, A. Dovnik, Ðuro Despot, Leyla Al Mahdawi, Marina Pranjic, Aleks Brumec, Matej Turkovic, J. Knez

#819 Primary results of DAYDREAM study, a real-world multicentre study on the efficacy of adjuvant chemotherapy in high-grade uterine sarcomas

Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.1117 Alejandro Gallego Martínez, N. Martín-Calvo, M. Meydanlı, Ghanim Khatib, D. Kaidarova, Ali Ayhan, Fulvio Borella, Marco Sanchez-Salcedo, M. Şancı, Claudia Bessa Bessa Pereira Chaves, Mervat Ali Mohamed Elsersy, R. Bolatbekova, George Vorias, A. Gil-Moreno, A. Perrone, Jagannath Mishra, Petra Zusterzeel, Vasilis Theodoulidis, Igor Aluloski, Cornelis DDe Kroon, Giuseppe Comerci, T. Toptaş, R. Fruscio, Octavio Arencibia Sanchez, Maria De Marino Caba, Eva-Maria Niine-Roolah, Belen Martin-Salamanca, Elena Cabezas López, P. Scollo, P. Blecharz, Franziska Siegenthaler, Mihai Bacila, Christine Gennigens, Antonio González-Martín, Luis Chiva de Agustín